منابع مشابه
Regarding cancer-related fatigue.
This is in response to the article “Cancer-related fatigue: a review”, published in April 2011 by Campos et al.1. We have a few concerns regarding certain statements made by the authors. The advances in oncology have rendered cancer from a universally lethal disease to a chronic condition for many and a curable illness for a few. Hence, the potential long-term adverse effects of supportive care...
متن کاملCancer-related fatigue: a review.
Cancer-related fatigue is the most prevalent cancer symptom, reported in 50%-90% of patients and severely impacts quality of life and functional capacity. The condition remains underreported and often goes untreated. Guidelines suggest screening for fatigue at the initial visit, when the diagnosis of advanced disease is made, and at each chemotherapy session, as well as the identification of tr...
متن کاملMechanisms of cancer-related fatigue.
Cancer-related fatigue (CRF) is one of the most prevalent symptoms patients with cancer experience, both during and after treatment. CRF is pervasive and affects patients' quality of life considerably. It is important, therefore, to understand the underlying pathophysiology of CRF in order to develop useful strategies for prevention and treatment. At present, the etiology of CRF is poorly under...
متن کاملPathophysiology of cancer-related fatigue.
Cancer-related fatigue (CRF) is influenced and modulated by a number of critical factors, and the mechanism that is both necessary and sufficient to induce development of severe fatigue in patients with cancer has not yet been identified. Specific research efforts to understand the factors that may contribute to CRF development have been made, including studies of the direct effects of tumor bu...
متن کاملPharmacologic treatment of cancer-related fatigue.
Fatigue is the most commonly reported symptom in patients with cancer, with a prevalence of over 60% reported in the majority of studies. This paper systematically reviews pharmacologic agents in the treatment of cancer-related fatigue (CRF). We conducted a literature review of clinical trials that assessed pharmacologic agents for the treatment of CRF. These agents include hematopoietics (for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista da Associação Médica Brasileira
سال: 2012
ISSN: 0104-4230
DOI: 10.1590/s0104-42302012000200002